PLx Pharma Inc (PLXP) Stock
PLXP is no longer traded. PLx Pharma was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 14, 2023 at $0.00.
PLx Pharma stock price history
PLXP final trading statistics
- Final close
- $0.00
- Final trading day
- Jun 14, 2023
- Market cap at delisting
- $2.53M
- Shares outstanding
- 29.14M
- Final 52-week range
- $0.00 – $3.08
- Avg. volume (final 3 mo.)
- 4,789,901
- All-time high (split-adj.)
- $8647.68 · Jul 2015
- All-time low (split-adj.)
- $0.00 · Jun 2023
- Return since IPO
- -100.0%
- Beta
- 3.92
- Book value / share
- $0.35
- Price / book
- 0.01
PLx Pharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $8.21M | -$56.8M | -$2.22 |
| FY2020 | $30.4K | -$16.2M | -$1.85 |
| FY2019 | $565.5K | -$26.1M | -$2.50 |
| FY2018 | $753.1K | $896.5K | $0.11 |
| FY2017 | $778.7K | -$15.3M | -$1.67 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About PLx Pharma Inc
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. On April 13, 2023, PLx Pharma Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
PLx Pharma stock FAQ
What happened to PLx Pharma stock?
PLx Pharma stock was delisted from the Nasdaq. Its final close was $0.00 on June 14, 2023.
Is PLXP stock still trading?
No. PLXP was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of PLXP stock?
PLXP closed at $0.00 on its final trading day, June 14, 2023, for a market value of about $2.53M.
What were PLx Pharma's revenue and earnings in its last full fiscal year?
PLx Pharma reported revenue of $8.21M and net income of -$56.8M in fiscal 2021, its last full year as a public company.
When did PLx Pharma go public?
PLx Pharma Inc stock began trading on March 13, 2014.